Science & Health Apr 14, 2020
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said. "Any pharmaceutical company manufacturing any treatment currently in clinical trials against coronavirus ...
